Stay updated on Ipilimumab Plus Talimogene Laherparepvec Clinical Trial
Sign up to get notified when there's something new on the Ipilimumab Plus Talimogene Laherparepvec Clinical Trial page.

Latest updates to the Ipilimumab Plus Talimogene Laherparepvec Clinical Trial page
- Check6 days agoChange DetectedRevision tag at the bottom updated from v3.6.6 to v3.7.0, indicating a new version of the ClinicalTrials.gov interface deployment. This change does not affect study data or content.SummaryDifference0.0%

- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedRevision: v3.6.6 appears, replacing the previous v3.6.5. This is a minor update to the page metadata and does not modify any study content.SummaryDifference0.0%

- Check27 days agoChange DetectedRemoval of the Melanoma entry, the related topics header, and the MedlinePlus Genetics link from the related topics section, reducing cross-links to external topics.SummaryDifference0.1%

- Check41 days agoChange DetectedAdded Melanoma and related topics (MedlinePlus Genetics) and updated the revision to v3.6.5, replacing the previous v3.6.4.SummaryDifference0.1%

- Check48 days agoChange DetectedThe melanoma entry and the related topics header (including MedlinePlus Genetics) were removed from the page's related topics area, reducing disease-specific navigation on this study record.SummaryDifference0.1%

- Check56 days agoChange DetectedMelanoma is added as a primary topic, and a related topics reference (MedlinePlus Genetics) is included, expanding the page's topic coverage. The revision status is updated from v3.6.3 to v3.6.4.SummaryDifference0.1%

Stay in the know with updates to Ipilimumab Plus Talimogene Laherparepvec Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ipilimumab Plus Talimogene Laherparepvec Clinical Trial page.